Bijan Andrew Niknam, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Matched-Pair Analysis | 1 | 2022 | 284 | 0.760 |
Why?
|
Subacute Care | 1 | 2022 | 179 | 0.680 |
Why?
|
Sample Size | 1 | 2022 | 841 | 0.620 |
Why?
|
Hospital Costs | 7 | 2021 | 947 | 0.590 |
Why?
|
Medicare | 16 | 2022 | 6770 | 0.490 |
Why?
|
Quality Indicators, Health Care | 2 | 2018 | 1792 | 0.360 |
Why?
|
Hospitals, Teaching | 3 | 2020 | 1156 | 0.340 |
Why?
|
Myocardial Infarction | 5 | 2024 | 11460 | 0.310 |
Why?
|
Surgical Procedures, Operative | 4 | 2021 | 1922 | 0.290 |
Why?
|
Nursing Staff, Hospital | 2 | 2020 | 348 | 0.240 |
Why?
|
General Surgery | 4 | 2018 | 1692 | 0.200 |
Why?
|
Quality of Health Care | 5 | 2018 | 4330 | 0.180 |
Why?
|
Nepal | 1 | 2022 | 305 | 0.180 |
Why?
|
Benchmarking | 3 | 2016 | 1045 | 0.170 |
Why?
|
Coronary Artery Disease | 1 | 2018 | 6403 | 0.150 |
Why?
|
Skilled Nursing Facilities | 1 | 2022 | 398 | 0.150 |
Why?
|
Economics, Hospital | 1 | 2020 | 210 | 0.150 |
Why?
|
United States | 18 | 2022 | 72334 | 0.130 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2020 | 495 | 0.130 |
Why?
|
Healthcare Disparities | 3 | 2018 | 3358 | 0.130 |
Why?
|
Clinical Competence | 3 | 2021 | 4792 | 0.130 |
Why?
|
Work Schedule Tolerance | 1 | 2020 | 551 | 0.130 |
Why?
|
Data Interpretation, Statistical | 2 | 2024 | 2691 | 0.130 |
Why?
|
Antilymphocyte Serum | 1 | 2017 | 487 | 0.120 |
Why?
|
Illinois | 4 | 2016 | 120 | 0.120 |
Why?
|
Financial Audit | 1 | 2014 | 5 | 0.120 |
Why?
|
Health Status Disparities | 2 | 2018 | 1852 | 0.120 |
Why?
|
Clinical Audit | 1 | 2014 | 29 | 0.120 |
Why?
|
Texas | 4 | 2016 | 404 | 0.110 |
Why?
|
End Stage Liver Disease | 1 | 2018 | 352 | 0.110 |
Why?
|
Appendicitis | 1 | 2020 | 675 | 0.110 |
Why?
|
Hospitals | 3 | 2021 | 3882 | 0.110 |
Why?
|
Hospital Mortality | 5 | 2020 | 5294 | 0.110 |
Why?
|
New York | 4 | 2016 | 874 | 0.100 |
Why?
|
Patient Readmission | 3 | 2022 | 3270 | 0.100 |
Why?
|
Kidney Transplantation | 2 | 2018 | 4234 | 0.100 |
Why?
|
Aged | 17 | 2022 | 169289 | 0.090 |
Why?
|
Anesthesia | 1 | 2020 | 1594 | 0.080 |
Why?
|
Patient Discharge | 1 | 2022 | 3443 | 0.080 |
Why?
|
Antibodies | 1 | 2017 | 2418 | 0.080 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2373 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2021 | 15631 | 0.080 |
Why?
|
Tissue Donors | 1 | 2018 | 2331 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 1 | 2017 | 3734 | 0.080 |
Why?
|
Hepatitis C | 1 | 2018 | 1584 | 0.080 |
Why?
|
Health Status | 2 | 2018 | 4077 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2018 | 4174 | 0.070 |
Why?
|
Health Care Costs | 1 | 2019 | 3242 | 0.070 |
Why?
|
Heart Failure | 2 | 2020 | 11669 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2022 | 80636 | 0.060 |
Why?
|
Humans | 24 | 2024 | 761504 | 0.060 |
Why?
|
Hospitalization | 2 | 2022 | 10723 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2018 | 58976 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10209 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12725 | 0.060 |
Why?
|
Algorithms | 2 | 2022 | 14031 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4761 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10508 | 0.050 |
Why?
|
Chronic Disease | 1 | 2018 | 9318 | 0.050 |
Why?
|
Models, Statistical | 4 | 2024 | 5079 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2538 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3627 | 0.050 |
Why?
|
Workplace | 2 | 2020 | 863 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15266 | 0.050 |
Why?
|
Female | 16 | 2021 | 392644 | 0.050 |
Why?
|
Male | 14 | 2021 | 360804 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9177 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 23995 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8599 | 0.040 |
Why?
|
Time Factors | 2 | 2018 | 39967 | 0.040 |
Why?
|
SEER Program | 2 | 2014 | 1450 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2018 | 21012 | 0.040 |
Why?
|
Benzofurans | 1 | 2018 | 139 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2018 | 64680 | 0.040 |
Why?
|
Quinoxalines | 1 | 2018 | 296 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2016 | 206 | 0.030 |
Why?
|
Young Adult | 1 | 2022 | 59243 | 0.030 |
Why?
|
Length of Stay | 2 | 2021 | 6425 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1668 | 0.030 |
Why?
|
Accreditation | 1 | 2017 | 473 | 0.030 |
Why?
|
Certification | 1 | 2017 | 418 | 0.030 |
Why?
|
Risk Factors | 2 | 2018 | 74206 | 0.030 |
Why?
|
Child | 1 | 2022 | 80153 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7827 | 0.030 |
Why?
|
Creatinine | 1 | 2018 | 1899 | 0.030 |
Why?
|
Imidazoles | 1 | 2018 | 1180 | 0.030 |
Why?
|
Drug Combinations | 1 | 2018 | 2048 | 0.030 |
Why?
|
Hepacivirus | 1 | 2018 | 1336 | 0.020 |
Why?
|
Rabbits | 1 | 2017 | 4772 | 0.020 |
Why?
|
Cohort Studies | 3 | 2020 | 41487 | 0.020 |
Why?
|
RNA, Viral | 1 | 2018 | 2846 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2176 | 0.020 |
Why?
|
Social Class | 1 | 2018 | 2004 | 0.020 |
Why?
|
Viral Load | 1 | 2018 | 3332 | 0.020 |
Why?
|
Internship and Residency | 2 | 2020 | 5880 | 0.020 |
Why?
|
Health Services Research | 1 | 2015 | 1812 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2018 | 3060 | 0.020 |
Why?
|
Middle Aged | 5 | 2018 | 220895 | 0.020 |
Why?
|
Medicaid | 1 | 2018 | 2818 | 0.020 |
Why?
|
Orthopedics | 1 | 2014 | 898 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6484 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9610 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12990 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5492 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10090 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 13367 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22176 | 0.010 |
Why?
|
Adult | 2 | 2018 | 221177 | 0.010 |
Why?
|
Animals | 1 | 2017 | 168459 | 0.000 |
Why?
|